Our unique and highly experienced research team forms the foundation of INA Pharma’s strength, bringing deep expertise in synthetic chemistry, process development, and scale-up of complex molecules. Supported by advanced R&D infrastructure and strong manufacturing capabilities, we specialize in developing efficient, non- infringing routes for challenging pharmaceutical intermediates and specialty chemicals.
With a strong commitment to quality, innovation, and customer collaboration, INA Pharma delivers reliable, scalable, and cost- effective solutions that help our partners accelerate product development and commercialization.
INA Pharma is driven by a uniquely strong research team with a broad spectrum of expertise in process development, medicinal chemistry, CRAMS/CDMO, multi-step organic synthesis, carbohydrate chemistry, peptides and peptidomimetics, and polymer chemistry. Our team consists of dynamic, competent, and highly committed pharmaceutical professionals, supported by a knowledgeable and experienced management team with deep industry experience.
We possess proven capabilities in handling challenging chemical transformations, including Grignard reactions, catalytic hydrogenation, and complex multi-step synthesis. Our expertise enables us to develop efficient and scalable manufacturing solutions for high-value pharmaceutical intermediates and specialty molecules.
Our scientists specialize in designing innovative and non-infringing synthetic routes for complex APIs and intermediates, enabling our partners to achieve faster market access, improved process efficiency, and significant cost advantages.
Our state-of-the-art R&D center works in close integration with manufacturing facilities to ensure seamless technology transfer and smooth scale-up from laboratory development to pilot and commercial-scale production.
INA Pharma operates with modern infrastructure, advanced process technologies, and well-equipped laboratories, enabling efficient development, scale-up, and production of complex chemical processes.
With agile scientific teams and flexible engagement models (FTE / FFS), we are able to adapt quickly to client requirements and deliver rapid turnaround with scalable solutions.
We specialize in complex intermediates, niche specialty chemicals, and difficult-to-manufacture molecules, enabling our partners to access high-value products and differentiated market opportunities.
Our business model is built on long-term collaboration and transparency. We work as an extension of our client’s scientific and development teams, delivering customized solutions while maintaining strict confidentiality and clear communication.
Our processes and manufacturing systems are aligned with global quality standards and regulatory expectations. We provide comprehensive technical documentation and data packages to support our partners’ development and regulatory requirements.
INA Pharma is committed to responsible manufacturing, environmental protection, and ethical business practices, ensuring that our operations contribute positively to society and sustainable supply chains.



